11th May 2007 15:57
Hutchison China Meditech Limited11 May 2007 Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) Results of Annual General Meeting London, Friday, 11 May 2007: Chi-Med is pleased to announce that all ordinaryresolutions put to its Annual General Meeting ("AGM") held on 11 May 2007 wereduly passed and the poll results of the resolutions were as follows: Number of Votes (%) Ordinary Resolutions For Against Withheld 1 To receive and consider the audited financial statements 40,537,607 0 0 and the reports of the directors and independent auditor (100%) (0%) (0%) for the year ended 31 December 2006. 2(a) To re-elect Mr. Christian Hogg as a director. 40,437,607 0 0 (100%) (0%) (0%) 2(b) To re-elect Mr. Patrick Wan as a director. 40,537,607 0 0 (100%) (0%) (0%) 2(c) To re-elect Mr. Christian Salbaing as a director. 40,537,607 0 0 (100%) (0%) (0%) 2(d) To re-elect Ms. Edith Shih as a director. 40,537,607 0 0 (100%) (0%) (0%) 2(e) To re-elect Mr. Michael Howell as a director. 40,537,607 0 0 (100%) (0%) (0%) 2(f) To re-elect Prof. Christopher Huang as a director. 40,537,607 0 0 (100%) (0%) (0%) 2(g) To re-elect Mr. Christopher Nash as a director. 40,537,607 0 0 (100%) (0%) (0%) 3 To re-appoint PricewaterhouseCoopers as the auditor of 40,537,607 0 0 the Company and authorise the board of directors to fix (100%) (0%) (0%) the auditor's remuneration. 4(a) Ordinary resolution on item 4(A) of the Notice of the 40,537,607 0 0 Meeting (To grant a general mandate to the directors of (100%) (0%) (0%) the Company to issue additional shares) 4(b) Ordinary resolution on item 4(B) of the Notice of the 40,537,607 0 0 Meeting (To grant a general mandate to the directors of (100%) (0%) (0%) the Company to repurchase shares of the Company) 5 Ordinary resolution on item 5 of the Notice of the 40,537,607 0 0 Meeting (100%) (0%) (0%) (To extend the general mandate to the directors of the Company to issue additional shares) As at the date of the AGM, the number of issued shares of Chi-Med was 51,212,121shares, which was the total number of shares entitling the holders to attend andvote on the resolutions proposed at the AGM. Ends Enquiries Citigate Dewe Rogerson Telephone: +44 (0) 20 7638 9571 Anthony Carlisle +44 (0) 7973 611 888Yvonne Alexander +44 (0) 7866 610 682 About Chi-Med Chi-Med is the holding company of a pharmaceutical and healthcare group basedprimarily in China and was admitted to trading on the Alternative InvestmentMarket of the London Stock Exchange in May 2006. Chi-Med is focused onresearching, developing, manufacturing, and selling pharmaceuticals, healthsupplements and other consumer health and personal care products derived fromTraditional Chinese Medicine and botanical ingredients. Chi-Med is majority owned by Hutchison Whampoa Limited, an internationalcorporation listed on the Main Board of The Stock Exchange of Hong Kong Limited. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Hutchmed